Lymphoma Drug Undergoing Trial Makes MS Relapses 5 Times Less Likely
A new lymphoma drug seeks to make multiple sclerosis (MS) relapses five times less likely.According to data released by the National ...
© 2022 Medical News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy.